Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -14.808% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] COc1cc(NC(=O)CN2CCN(S(=O)(=O)/C=C/c3ccccc3)CC2)cc(OC)c1OC
[b] O=C(CCC(=O)c1ccc(Cl)s1)Nc1ncccc1O
Answer: a. COc1cc(NC(=O)CN2CCN(S(=O)(=O)/C=C/c3ccccc3)CC2)cc(OC)c1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc(NC(=O)CN2CCN(S(=O)(=O)/C=C/c3ccccc3)CC2)cc(OC)c1OC
COc1cc(NC(=O)CN2CCN(S(=O)(=O)/C=C/c3ccccc3)CC2)cc(OC)c1OC
2-[4-[(E)-2-phenylethenyl]sulfonylpiperazin-1-yl]-N-(3,4,5-trimethoxyphenyl)acetamide